Putnam BioRevolution ETF
SYNB
SYNB was delisted on the 13th of November, 2025.
4 hedge funds and large institutions have $3.83M invested in Putnam BioRevolution ETF in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0.22% less ownership
Funds ownership: 72.18% → 71.96% (-0.22%)
10% less capital invested
Capital invested by funds: $4.26M → $3.83M (-$434K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$12.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Franklin Resources
San Mateo,
California
| $3.7M | – | – | – |
|
|
2
Royal Bank of Canada
Toronto,
Ontario, Canada
| $134K | -$12.2K | -390 | -8% |
|
3
UBS Group
Zurich,
Switzerland
| $325 | – | – | – |
|
4
Osaic Holdings
Scottsdale,
Arizona
| $59 | – | – | – |
|
SYNB Hedge Fund Activity: Q4 2024 in Review
4 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Putnam BioRevolution ETF (SYNB) for Q4 2024, worth a combined $3.83M — down 10% from $4.26M a quarter earlier.
Fund positioning in SYNB was balanced in Q4 2024: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Royal Bank of Canada, cutting an estimated $12.2K.
- 4 institutional investors held Putnam BioRevolution ETF (SYNB) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $3.83M of Putnam BioRevolution ETF stock for Q4 2024, down 10% quarter-over-quarter.
- 0 funds opened new Putnam BioRevolution ETF positions in Q4 2024 and 0 closed out.
- The largest Putnam BioRevolution ETF seller in Q4 2024 was Royal Bank of Canada, an estimated $12.2K sold.
Based on aggregated 13F filings for Q4 2024.